Five Percent Monolaurin Vaginal Gel for the Treatment of Bacterial Vaginosis: A Randomized Placebo-Controlled Trial

MLA

Mancuso, Abigail C., et al. “Five Percent Monolaurin Vaginal Gel for the Treatment of Bacterial Vaginosis: A Randomized Placebo-Controlled Trial.” Journal of Lower Genital Tract Disease, vol. 24, no. 3, July 2020, pp. 277–83. EBSCOhost, https://doi.org/10.1097/LGT.0000000000000543.

APA

Mancuso, A. C., Widdice, L. E., Hughes, B. L., Schlievert, P., Swamy, G. K., Stockdale, C. K., Bernstein, D. I., & Winokur, P. L. (2020). Five Percent Monolaurin Vaginal Gel for the Treatment of Bacterial Vaginosis: A Randomized Placebo-Controlled Trial. Journal of Lower Genital Tract Disease, 24(3), 277–283. https://doi.org/10.1097/LGT.0000000000000543

Chicago

Mancuso, Abigail C., Lea E. Widdice, Brenna L. Hughes, Patrick Schlievert, Geeta K. Swamy, Colleen K. Stockdale, David I. Bernstein, and Patricia L. Winokur. 2020. “Five Percent Monolaurin Vaginal Gel for the Treatment of Bacterial Vaginosis: A Randomized Placebo-Controlled Trial.” Journal of Lower Genital Tract Disease 24 (3): 277–83. doi:10.1097/LGT.0000000000000543.